Cargando…

Chronic myeloid leukemia in children, do we have all the answers?

Detalles Bibliográficos
Autor principal:	Bansal, Shweta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236692/ https://www.ncbi.nlm.nih.gov/pubmed/25422800 http://dx.doi.org/10.4103/2278-330X.142940

Ejemplares similares

Asthma and COVID-19: do we finally have answers?
por: Eger, Katrien, et al.
Publicado: (2021)

Surgical management of intermittent exotropia: do we have an answer for all?
por: Chougule, Pratik, et al.
Publicado: (2019)

Roxadustat: Do we know all the answers?
por: Li, Qiu-Yu, et al.
Publicado: (2023)

Drug Therapy For Preventing Ventricular Arrhythmia In Brugada syndrome: Do We Have The Answers Yet?
por: Bohora, Shomu
Publicado: (2013)

Bone-Targeted Agents in Breast Cancer: Do We Now Have All the Answers?
por: Ottewell, Penny, et al.
Publicado: (2019)

Obstructive Sleep Apnea and Right Ventricular Remodeling: Do We Have All the Answers?
por: Tadic, Marijana, et al.
Publicado: (2023)

The Role of Revascularization in Chronic Stable Angina: Do We Have an Answer?
por: Ahmed, Talha
Publicado: (2020)

We thrive not when we’ve done it all, but when we still have more to do (S. Lewis)
por: Hefti, F, et al.
Publicado: (2022)

Chronic myeloid leukemia in the Imatinib era – Compilation of Indian data from 22 centers involving 8115 patients
por: Parikh, Purvish, et al.
Publicado: (2013)

Continuous Glucose Monitoring in Pregnancy: We Have the Technology but Not All the Answers
por: Murphy, Helen R.
Publicado: (2013)

Chronic myeloid leukemia data from India
por: Bansal, Shweta, et al.
Publicado: (2013)

Unmet needs in clinical trials in CKD: questions we have not answered and answers we have not questioned
por: Levin, Adeera, et al.
Publicado: (2022)

Patent Ductus Arteriosus in Preterm Infants: Do We Have the Right Answers?
por: Abdel-Hady, Hesham, et al.
Publicado: (2013)

Safety of anesthetic exposure on the developing brain – Do we have the answer yet?
por: Gupta, Anju, et al.
Publicado: (2020)

Do We Have the Spark?
por: Rupel, Valentina Prevolnik, et al.
Publicado: (2022)

Do we have all the facts to determine the impact of bacillus Calmette-Guérin therapy on bladder cancer?
por: Mahendran, Ratha
Publicado: (2018)

Epicardial mapping and ablation of arrhythmias: is magnetic navigation the answer we have been waiting for?
por: de Groot, J. R., et al.
Publicado: (2013)

Asciminib in chronic myeloid leukemia: many questions still remain to be answered
por: Eşkazan, Ahmet Emre
Publicado: (2021)

Extramedullary Manifestations of Chronic Myelomonocytic Leukemia: Do We Treat like an Acute Myeloid Leukemia?
por: Pudasainee, Prasun, et al.
Publicado: (2019)

Recent advances in understanding chronic myeloid leukemia: where do we stand?
por: Kumar, Rahul, et al.
Publicado: (2021)

Do all children in South Africa have access to dedicated paediatric intensive care?
por: Goussard, Pierre
Publicado: (2022)

Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
por: Abdulmawjood, Bilal, et al.
Publicado: (2021)

It's only infection prevention, but infection prevention is all we have
por: Hegde, Ashit V.
Publicado: (2015)

Fusion genes in acute myeloid leukemia: do acute myeloid leukemia diagnostics need to fuse with RNA-sequencing?
por: Thol, Felicitas
Publicado: (2022)

All for one and one for All? – Do we need a VT network?
por: Klein, Helmut.U.
Publicado: (2021)

Return to duty/play after exertional heat injury: do we have all the answers? A lesson from two case studies
por: Ketko, Itay, et al.
Publicado: (2015)

Immune control in chronic myeloid leukemia
por: Ilander, Mette, et al.
Publicado: (2017)

The transformative journey of chronic myeloid leukemia
por: Neelakantan, Pratap, et al.
Publicado: (2018)

Fluids and Early Vasopressors in the Management of Septic Shock: Do We Have the Right Answers Yet?
por: Carlos Sanchez, E., et al.
Publicado: (2023)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Sequencing Technologies and Analyses: Where Have We Been and Where Are We Going?
por: Bansal, Vikas, et al.
Publicado: (2019)

Emergence from anaesthesia: Have we got it all smoothened out?
por: Bhaskar, S Bala
Publicado: (2013)

Do We Have Real Poverty in the United States of America?
por: Braveman, Paula
Publicado: (2007)

Chronic myeloid leukemia in India
por: Goldman, John M.
Publicado: (2013)

If All That You Have Is a Hammer…: Can We Phenotype Our Patients with Chronic Obstructive Pulmonary Disease?
por: Chapman, Kenneth R.
Publicado: (2021)

Imatinib in chronic myeloid leukemia elderly patients
por: Gugliotta, Gabriele, et al.
Publicado: (2011)

What Is Safe Limit of the Perforator Flap in Lower Extremity Reconstruction? Do We Have Answers Yet?
por: Panse, Nikhil S., et al.
Publicado: (2011)

Do we all agree that the future of pancreaticoduodenectomy lies in how effectively we use robots?
por: Lee, Jae Hoon
Publicado: (2023)

We all have a role to play in suicide prevention
por: Carpenter, Delesha
Publicado: (2022)

What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?
por: Delgado, Nancy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8hatlsqevejpg72leuotljht67